SCHEMBL6695623

SCHEMBL6695623

CCOC(=O)CCc1cc(C)ccc1S(=O)(=O)c1ccc(C[C@@H](C)NC(C(=O)OC(C)(C)C)[C@H](O)c2cccc(Cl)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 10/20 0.35
ADRB2 P07550 8/20 0.35
ADRB1 P08588 8/20 0.35
GLA P06280 1/20 0.35
CYP2D6 P10635 2/20 0.34
CYP3A4 P08684 1/20 0.34
HIF1A Q16665 1/20 0.34
SLC2A1 P11166 1/20 0.34
CNR2 P34972 1/20 0.34
ADRA1D P25100 1/20 0.34
ADRA1A P35348 1/20 0.34
ADRA1B P35368 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
MMEL1 Q495T6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6682388 0.94 ADRB3 (0.38) ADRB3ADRB2ADRB1GLACYP2D6
SCHEMBL6677035 0.82 ADRB3 (0.36) ADRB3ADRB2ADRB1GLACYP2D6
SCHEMBL6677749 0.82 ADRB3 (0.36) ADRB3ADRB2ADRB1GLACYP2D6
SCHEMBL6678549 0.82 ADRB3 (0.40) ADRB3ADRB2ADRB1GLACYP2D6
SCHEMBL6678508 0.81 BACE1 (0.36) ADRB3ADRB2ADRB1GLACYP2D6
SCHEMBL6678505 0.81 BACE1 (0.36) ADRB3ADRB2ADRB1GLACYP2D6
SCHEMBL6677323 0.79 ADRB3 (0.40) ADRB3ADRB2ADRB1GLACYP2D6
SCHEMBL6676354 0.78 ADRB3 (0.39) ADRB3ADRB2ADRB1GLACYP2D6
SCHEMBL6679024 0.78 ADRB3 (0.39) ADRB3ADRB2ADRB1GLACYP2D6
SCHEMBL6676153 0.75 ADRB3 (0.37) ADRB3ADRB2ADRB1GLACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004045610-A1 AMINOALCOHOL DERIVATIVES AND THEIR USE AS BETA-3 ADRENERGIC RECEPTOR AGONISTS FUJISAWA PHARMACEUTICAL CO., LTD (JP) 2004-06-03 WO disclosed